Strengthening GMP Compliance Through Insight, Action & Leadership
EPiC are expanding our range of virtual symposium events with the launch of our first GMP focused symposium on Tuesday 3rd November 2026.
EPiC’s view on Leading and Influencing GMP Compliance.
- Tuesday 3rd November 2026. 9:00 to 12:30 (GMT)
- £200.00 + VAT per delegate
The EPiC GMP Symposium 2026 is a half‑day virtual event focused on current and emerging challenges in Good Manufacturing Practice, with a particular emphasis on biological products, leadership influence, and effective regulatory oversight.
Bringing together experienced industry professionals and former MHRA inspectors, the symposium combines regulatory updates with practical, real‑world insight into GMP audits of biological substances and products, GMP compliance for APIs, how to influence senior management to drive compliance improvements, and managing unexpected compliance failures. The programme is designed to help delegates understand not only regulatory expectations, but how to apply them effectively in complex manufacturing environments.
With a balance of technical, regulatory, and leadership‑focused sessions, the symposium offers practical guidance, expert perspectives, and opportunities for discussion through an expert panel Q&A.
This GMP symposium is designed for professionals working within, or overseeing, GMP‑regulated manufacturing activities, including Qualified Persons (QPs) and Deputy QPs, Quality Assurance and Compliance professionals, GMP Auditors and Inspection Readiness Leads, Manufacturing, Technical, and Operations Managers, Regulatory and Quality Leaders, Professionals involved in biological, biotech, API, or IMP manufacturing.
It is particularly relevant for those who need to influence GMP compliance, engage senior management, prepare for inspections, or manage complex quality risks in evolving regulatory environments.
The symposium will begin with an overview of current GMP developments, highlighting recent updates to guidance, emerging regulatory “hot topics”, and areas likely to attract increased regulatory scrutiny. This will help delegates stay informed and anticipate where regulatory expectations are heading.
You will gain in‑depth insight into conducting effective, risk‑based GMP audits for biological products, from a former MHRA Lead GMP Inspector’s perspective. Across two sessions covering both drug substance and drug product, we will explore how to approach audit planning and conduct, identifying triggers for deeper investigation, and understanding differences in expectations between IMPs and licensed products.
Additional sessions will explore how GMP professionals can better influence compliance by managing upwards, offering practical strategies for communicating risk, presenting PQS metrics, escalating issues effectively, and engaging senior management in meaningful quality leadership. You will also gain clarity on current and future GMP expectations for APIs, including key risk areas, auditing considerations, and the implications of EU GMP Annex 15 becoming mandatory.
The symposium will conclude with a practical session on managing unexpected compliance failures, walking through investigation, risk assessment, root cause analysis, CAPA development, documentation, and communication. Alongside an expert panel Q&A, delegates will leave with increased regulatory awareness, practical tools they can apply immediately, and greater confidence in managing risk and driving sustained GMP compliance.
LEARN how to utilise practical solutions to overcome GMDP compliance challenges
CPD Continuous Professional Development to improve workplace skills and knowledge
COLLABORATE with other Pharmaceutical Industry delegates
CONNECT with former MHRA GMDP Inspectors and EPiC Consultants
CONNECT with former MHRA GMDP Inspectors and EPiC Consultants
VALUE for money, presenting a wide range of topics from regulatory experts